- Home
- KVHI vs KYTX Comparison
KVHI vs KYTX Comparison
Compare KVHI & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KVHI
- KYTX
- Stock Information
- Founded
- KVHI 1978
- KYTX 2018
- Country
- KVHI United States
- KYTX United States
- Employees
- KVHI N/A
- KYTX N/A
- Industry
- KVHI Radio And Television Broadcasting And Communications Equipment
- KYTX
- Sector
- KVHI Technology
- KYTX
- Exchange
- KVHI Nasdaq
- KYTX NYSE
- Market Cap
- KVHI 105.7M
- KYTX 125.2M
- IPO Year
- KVHI 1996
- KYTX 2024
- Fundamental
- Price
- KVHI $5.30
- KYTX $1.93
- Analyst Decision
- KVHI
- KYTX Buy
- Analyst Count
- KVHI 0
- KYTX 4
- Target Price
- KVHI N/A
- KYTX $19.00
- AVG Volume (30 Days)
- KVHI 33.9K
- KYTX 294.1K
- Earning Date
- KVHI 03-06-2025
- KYTX 03-27-2025
- Dividend Yield
- KVHI N/A
- KYTX N/A
- EPS Growth
- KVHI N/A
- KYTX N/A
- EPS
- KVHI N/A
- KYTX N/A
- Revenue
- KVHI $113,828,000.00
- KYTX N/A
- Revenue This Year
- KVHI N/A
- KYTX N/A
- Revenue Next Year
- KVHI N/A
- KYTX N/A
- P/E Ratio
- KVHI N/A
- KYTX N/A
- Revenue Growth
- KVHI N/A
- KYTX N/A
- 52 Week Low
- KVHI $4.17
- KYTX $1.90
- 52 Week High
- KVHI $6.16
- KYTX $25.84
- Technical
- Relative Strength Index (RSI)
- KVHI 57.91
- KYTX 27.74
- Support Level
- KVHI $5.17
- KYTX $2.20
- Resistance Level
- KVHI $5.41
- KYTX $2.57
- Average True Range (ATR)
- KVHI 0.27
- KYTX 0.19
- MACD
- KVHI 0.07
- KYTX -0.02
- Stochastic Oscillator
- KVHI 100.00
- KYTX 4.00
About KVHI KVH Industries Inc.
KVH Industries Inc provide integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. The Company operates in a number of geographic areas, including internationally. The Revenues are generated from international locations, mainly consisting of Singapore, Canada, European Union countries and other European countries, countries in Africa, Asia/Pacific and the Middle East, and India.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.